These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 28641625

  • 1. [Effect of GSTP1 and MTHFR Gene Polymorphism on Side Effects of HD-MTX in ALL Children].
    Li F, Yin DD, Zhou XL, Ma JM, Guo HM, Meng L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):723-728. PubMed ID: 28641625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, Topcuoglu N, Aksoylar S, Cinar M, Tetik A, Eroglu Z.
    Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036
    [Abstract] [Full Text] [Related]

  • 5. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
    Zhou Y, He H, Ding L, Wang T, Liu X, Zhang M, Zhang A, Fu J.
    Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084
    [Abstract] [Full Text] [Related]

  • 6. Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia.
    Chae H, Kim M, Choi SH, Kim SK, Lee JW, Chung NG, Cho B, Kim Y.
    J Chemother; 2020 Sep; 32(5):251-259. PubMed ID: 32431230
    [Abstract] [Full Text] [Related]

  • 7. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
    Yang L, Hu X, Xu L.
    Tumour Biol; 2012 Oct; 33(5):1445-54. PubMed ID: 22528943
    [Abstract] [Full Text] [Related]

  • 8. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.
    Imanishi H, Okamura N, Yagi M, Noro Y, Moriya Y, Nakamura T, Hayakawa A, Takeshima Y, Sakaeda T, Matsuo M, Okumura K.
    J Hum Genet; 2007 Oct; 52(2):166-171. PubMed ID: 17180579
    [Abstract] [Full Text] [Related]

  • 9. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J, Kralovánszky J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G.
    Anticancer Res; 2008 Oct; 28(5B):3051-4. PubMed ID: 19031955
    [Abstract] [Full Text] [Related]

  • 10. Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy.
    Yanagimachi M, Goto H, Kaneko T, Naruto T, Sasaki K, Takeuchi M, Tanoshima R, Kato H, Yokosuka T, Kajiwara R, Fujii H, Tanaka F, Goto S, Takahashi H, Mori M, Kai S, Yokota S.
    Int J Hematol; 2013 Dec; 98(6):702-7. PubMed ID: 24241962
    [Abstract] [Full Text] [Related]

  • 11. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
    Faganel Kotnik B, Grabnar I, Bohanec Grabar P, Dolžan V, Jazbec J.
    Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
    [Abstract] [Full Text] [Related]

  • 12. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
    Eissa DS, Ahmed TM.
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
    [Abstract] [Full Text] [Related]

  • 13. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T.
    Cancer Res; 2005 Mar 15; 65(6):2482-7. PubMed ID: 15781665
    [Abstract] [Full Text] [Related]

  • 14. Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis.
    Bernbeck B, Mauz-Körholz C, Zotz RB, Göbel U.
    Klin Padiatr; 2003 Mar 15; 215(6):327-31. PubMed ID: 14677097
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis.
    Zhao M, Liang L, Ji L, Chen D, Zhang Y, Zhu Y, Ongaro A.
    Pharmacogenomics; 2016 Jun 15; 17(9):1005-17. PubMed ID: 27270164
    [Abstract] [Full Text] [Related]

  • 17. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
    El-Khodary NM, El-Haggar SM, Eid MA, Ebeid EN.
    Med Oncol; 2012 Sep 15; 29(3):2053-62. PubMed ID: 21644011
    [Abstract] [Full Text] [Related]

  • 18. Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia.
    Zahra FT, Nahid NA, Islam MR, Al-Mamun MMA, Apu MNH, Nahar Z, Kabir AL, Biswas SK, Ahmed MU, Islam MS, Hasnat A.
    Clin Lymphoma Myeloma Leuk; 2020 Feb 15; 20(2):e58-e65. PubMed ID: 31884153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R, Rentsch K, Di Paolo E, Popovic MB.
    Pediatr Blood Cancer; 2008 Jan 15; 50(1):154-6. PubMed ID: 17387702
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.